Company Directory - World Vaccine Congress
Company Details - World Vaccine Congress
World Vaccine Congress
An annual global event focusing on vaccine development, production, and distribution.
CCI Score
CCI Score: World Vaccine Congress
43.66
-0.03%
Latest Event
World Vaccines Congress Policy Discussion on Access and Equity
At the 2024 World Vaccines Congress in Washington, vaccine policy experts engaged in discussions addressing evolving immunization strategies amid challenges such as climate change and shifting demographics. Topics included adapting ACIP recommendations, improving pharmacy channels for vaccination, and strategies for equitable vaccine access.
Take Action
So what can you do? Support by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
DISSENTER
World Vaccine Congress is currently rated as a Dissenter.
Latest Events
- APR172024
At the 2024 World Vaccines Congress in Washington, vaccine policy experts engaged in discussions addressing evolving immunization strategies amid challenges such as climate change and shifting demographics. Topics included adapting ACIP recommendations, improving pharmacy channels for vaccination, and strategies for equitable vaccine access.
+40
Public and Political Behavior
April 4
The congress provided a forum for experts to discuss and promote progressive vaccine policies aimed at improving public health and equitable access, fostering transparency and evidence-based decision making. This kind of inclusive public policy discussion supports anti-authoritarian and progressive objectives by focusing on equitable health outcomes for marginalized populations.
Key Policy and Access Themes from the World Vaccines Congress
- APR012024
The World Vaccine Congress, occurring from April 1 to 4, 2024, brings together government leaders, renowned scientists, and industry executives to advance global vaccine development and promote public health through collaborative efforts.
+30
Public and Political Behavior
April 4
The event assembles top public officials, scientific experts, and industry stakeholders in a forum that emphasizes democratic collaboration, transparency, and evidence-based public health policies. This initiative supports anti-authoritarian principles and reinforces the importance of inclusive governance in addressing global health challenges.
World Vaccine Congress Draws Leaders from Government, Science and Industry
- APR012024
The World Vaccine Congress is hosting its 2024 event from April 1-4, bringing together leading government officials, researchers, and industry executives to foster collaboration on vaccine development and public health policy.
+70
Public and Political Behavior
April 4
The event convenes top policymakers, scientists, and industry leaders in a transparent forum, promoting collaborative public health dialogue and progressive engagement in vaccine development. This effort supports democratic participation in global health and exemplifies anti-fascist, inclusive practices.
World Vaccine Congress Draws Leaders from Government, Science and Industry
- APR062023
At its 2023 congress, the event panel addressed vaccine hesitancy and advocated for grassroots engagement and supportive legislation to strengthen vaccine infrastructure, as highlighted by congressional testimony.
+80
Public and Political Behavior
April 4
The congress featured a panel discussion that promoted public engagement and policy advocacy to improve vaccine confidence and infrastructure. This kind of grassroots political behavior supports progressive public health measures and counters authoritarian tendencies by empowering community action.
World Vaccine Congress 2023: Addressing hesitancy - Bio.News
- APR032023
The 2023 World Vaccine Congress, held from April 3 to 6 in Washington, D.C., provided a platform for global experts to discuss sustainable vaccine manufacturing, technology transfer, and public-private partnerships aimed at increasing equitable vaccine access, particularly in Africa.
+50
Public and Political Behavior
April 4
The congress fostered significant public policy dialogue by uniting government bodies, international organizations, and private sector partners. This collaboration helped promote transparent, inclusive discussions around vaccine manufacturing and equitable public health initiatives, aligning with progressive public interest.
+40
Business Practices and Ethical Responsibility
April 4
The event emphasized sustainable business practices by showcasing responsible manufacturing, technology transfer, and partnerships that contribute to workforce development and equitable access to life-saving vaccines.
+40
Technology and Services Impact
April 4
The congress showcased cutting-edge vaccine technologies and innovations across the vaccine value chain. This focus on technological advancements and effective technology transfer plays a crucial role in addressing global health challenges.
+30
Economic and Structural Influence
April 4
By promoting regional manufacturing and economic collaboration, the event underlined the importance of building resilient local vaccine production ecosystems, which can contribute to broader economic and social development.
- APR032023
During the annual World Vaccine Congress held from April 3-6, 2023 at the Walter E. Washington Convention Center in Washington, D.C., global health experts discussed sustainable manufacturing practices, technology transfer, and regional vaccine production initiatives. Key collaborations included Africa CDC and the Mastercard Foundation, emphasizing ethical funding, technology innovation, and equitable access.
+50
Public and Political Behavior
April 4
The congress showcased strong public engagement and multi-stakeholder collaboration with government agencies and international organizations, reinforcing transparent and inclusive public-sector partnerships in health.
+40
Business Practices and Ethical Responsibility
April 4
The event emphasized ethical business practices by promoting equitable access to vaccines, sustainable manufacturing, and responsible partnerships, aligning with progressive initiatives to support public health.
+50
Technology and Services Impact
April 4
Innovative technologies in vaccine research, development, and manufacturing were highlighted, demonstrating a robust impact on advancing public health through technological improvements.
+40
Economic and Structural Influence
April 4
The congress promoted discussions on sustainable economic models for vaccine production, with an emphasis on capacity building and infrastructure development in Africa, strengthening overall economic and structural resilience.
Alternatives
Santa Monica, United States
77.83
New York, United States
55.09
Kyiv, Ukraine
41.53
Washington, United States
28.61
Washington, D.C., United States
28.58
Washington, D.C., United States
8.75
Thailand
0.00
Corporation
63.88
Corporation
38.27
Corporation
13.77
Industries
- 541611
- Administrative Management and General Management Consulting Services
- 541720
- Research and Development in the Social Sciences and Humanities
- 621511
- Medical Laboratories